Cargando…
Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
Peroxisome proliferator-activated receptor alpha (PPARα) and gamma (PPARγ) agonists have anti-inflammatory and anti-neovascularization effects, but few reports have tested the combination of PPARα and PPARγ agonists. In this study, we investigated the therapeutic effects of ophthalmic solutions of a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404145/ https://www.ncbi.nlm.nih.gov/pubmed/32707656 http://dx.doi.org/10.3390/ijms21145093 |
_version_ | 1783567087247032320 |
---|---|
author | Nakano, Yuji Arima, Takeshi Tobita, Yutaro Uchiyama, Masaaki Shimizu, Akira Takahashi, Hiroshi |
author_facet | Nakano, Yuji Arima, Takeshi Tobita, Yutaro Uchiyama, Masaaki Shimizu, Akira Takahashi, Hiroshi |
author_sort | Nakano, Yuji |
collection | PubMed |
description | Peroxisome proliferator-activated receptor alpha (PPARα) and gamma (PPARγ) agonists have anti-inflammatory and anti-neovascularization effects, but few reports have tested the combination of PPARα and PPARγ agonists. In this study, we investigated the therapeutic effects of ophthalmic solutions of agonists of PPARα, PPARγ, and the combination in a rat corneal alkali burn model. After alkali injury, an ophthalmic solution of 0.05% fenofibrate (PPARα group), 0.1% pioglitazone (PPARγ group), 0.05% fenofibrate + 0.1% pioglitazone (PPARα+γ group), or vehicle (vehicle group) was topically instilled onto the rat’s cornea twice a day. After instillation, upregulation was seen of PPAR mRNA corresponding to each agonist group. Administration of agonists for PPARα, PPARγ, and PPARα+γ suppressed inflammatory cells, neovascularization, and fibrotic changes. In addition, the PPARγ agonist upregulated M2 macrophages, which contributed to wound healing, whereas the PPARα agonist suppressed immature blood vessels in the early phase. Administration of PPARα+γ agonists showed therapeutic effects in corneal wound healing, combining the characteristics of both PPARα and PPARγ agonists. The results indicate that the combination of PPARα and γ agonists may be a new therapeutic strategy. |
format | Online Article Text |
id | pubmed-7404145 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74041452020-08-11 Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model Nakano, Yuji Arima, Takeshi Tobita, Yutaro Uchiyama, Masaaki Shimizu, Akira Takahashi, Hiroshi Int J Mol Sci Article Peroxisome proliferator-activated receptor alpha (PPARα) and gamma (PPARγ) agonists have anti-inflammatory and anti-neovascularization effects, but few reports have tested the combination of PPARα and PPARγ agonists. In this study, we investigated the therapeutic effects of ophthalmic solutions of agonists of PPARα, PPARγ, and the combination in a rat corneal alkali burn model. After alkali injury, an ophthalmic solution of 0.05% fenofibrate (PPARα group), 0.1% pioglitazone (PPARγ group), 0.05% fenofibrate + 0.1% pioglitazone (PPARα+γ group), or vehicle (vehicle group) was topically instilled onto the rat’s cornea twice a day. After instillation, upregulation was seen of PPAR mRNA corresponding to each agonist group. Administration of agonists for PPARα, PPARγ, and PPARα+γ suppressed inflammatory cells, neovascularization, and fibrotic changes. In addition, the PPARγ agonist upregulated M2 macrophages, which contributed to wound healing, whereas the PPARα agonist suppressed immature blood vessels in the early phase. Administration of PPARα+γ agonists showed therapeutic effects in corneal wound healing, combining the characteristics of both PPARα and PPARγ agonists. The results indicate that the combination of PPARα and γ agonists may be a new therapeutic strategy. MDPI 2020-07-19 /pmc/articles/PMC7404145/ /pubmed/32707656 http://dx.doi.org/10.3390/ijms21145093 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nakano, Yuji Arima, Takeshi Tobita, Yutaro Uchiyama, Masaaki Shimizu, Akira Takahashi, Hiroshi Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model |
title | Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model |
title_full | Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model |
title_fullStr | Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model |
title_full_unstemmed | Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model |
title_short | Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model |
title_sort | combination of peroxisome proliferator-activated receptor (ppar) alpha and gamma agonists prevents corneal inflammation and neovascularization in a rat alkali burn model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404145/ https://www.ncbi.nlm.nih.gov/pubmed/32707656 http://dx.doi.org/10.3390/ijms21145093 |
work_keys_str_mv | AT nakanoyuji combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel AT arimatakeshi combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel AT tobitayutaro combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel AT uchiyamamasaaki combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel AT shimizuakira combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel AT takahashihiroshi combinationofperoxisomeproliferatoractivatedreceptorpparalphaandgammaagonistspreventscornealinflammationandneovascularizationinaratalkaliburnmodel |